Gastrointestinal Radiofrequency Ablation Systems Market Size & Share, by Type (Benchtop, Trolley); Application (Surgical Oncology, Pain Management, Cardiology & Cardiac Rhythm Management, Cosmetology, Gynecology); and by End-user (Hospitals, Cancer Specialty Clinic) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 4032
  • Published Date: Sep 26, 2023
  • Report Format: PDF, PPT

Top Featured Companies Dominating the Global Gastrointestinal Radiofrequency Ablation Systems Market

    • Medtronic plc
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Royal Philips
    • Boston Scientific Corporation
    • Johnson & Johnson

Browse Key Market Insights with Data Illustration:


In The News

  • June 2020: Boston Scientific Corporation introduced DIRECTSENSE Technology, a device for tracking how radiofrequency (RF) energy is delivered during cardiac ablation procedures. Furthermore, the DIRECTSENSE Technology offers information on the impedance around the catheter tip to gauge the tissue's responsiveness to RF radiation.
  • August 2022: Medtronic plc acquired Affera, Inc. to extend the first-ever cardiac mapping and navigation platform, which includes radiofrequency ablation solution, to the company's cardiac ablation product line. Further, this acquisition gives the company access to the Affera Prism-1 cardiac mapping and navigation platform, which is compatible with both Medtronic therapeutic catheters and a variety of competing technologies.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 4032
  • Published Date: Sep 26, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Growing preference for minimally invasive procedures and the growing prevalence of gastrointestinal diseases are the major factors driving the market growth.

The market size of gastrointestinal radiofrequency ablation systems is anticipated to attain a CAGR of ~7% over the forecast period, i.e., 2023 – 2035.

The major players in the market are ATRICURE, INC, Royal Philips, Boston Scientific Corporation, Medtronic plc, Johnson & Johnson, Japan Lifeline Co. Ltd, Medtronic Japan Co. Ltd, Olympus Corporation, Astellas Pharma Inc. and others

The hospital segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying